Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
01:11:59 EDT Sun 05 Oct 2025
Enter Symbol
or Name
USA
CA



Q:FOLD - AMICUS THERAPEUTICS INC - https://www.amicustherapeutics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
FOLD - Q2.07.79·8.580.28.20-0.05-0.66,600.253,17524,4168.25  8.585  8.1112.65  5.5119:53:16Sep 0815 min RT 2¢

Recent Trades - Last 10 of 24416
Time ETExPriceChangeVolume
19:53:16Q8.350.1020
19:44:52Q8.580.3350
18:42:23Q8.20-0.056
17:58:15Q8.280.031
16:20:00Q8.20-0.051,282
16:10:04Q8.20-0.051
16:10:04Q8.20-0.051
16:06:44Q8.10-0.151
16:04:13Q8.20-0.051
16:04:09Q8.20-0.051

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-09-08 09:00U:FOLDNews ReleaseNew 4-Year Data for Pombiliti(TM) (cipaglucosidase alfa-atga) + Opfolda(TM) (miglustat) Presented at ICIEM
2025-08-29 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at Upcoming Investor Conferences in September 2025
2025-07-31 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Second Quarter 2025 Financial Results and Corporate Updates
2025-07-21 07:00U:FOLDNews ReleaseAmicus Therapeutics to Announce Second Quarter 2025 Financial Results on July 31, 2025
2025-06-25 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Approval of Pombiliti(TM) (cipaglucosidase alfa) + Opfolda(TM) (miglustat) in Japan
2025-06-03 07:00U:FOLDNews ReleaseNew Analysis of Pombiliti(TM) (cipaglucosidase alfa-atga) + Opfolda(TM) (miglustat) Published in Muscle and Nerve
2025-05-30 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at Upcoming Investor Conferences in June 2025
2025-05-07 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at the Bank of America 2025 Health Care Conference
2025-05-01 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces First Quarter 2025 Financial Results and Corporate Updates
2025-04-30 19:13U:FOLDNews ReleaseDimerix and Amicus Therapeutics Announce Exclusive License Agreement for DMX-200 in the United States
2025-04-21 07:00U:FOLDNews ReleaseAmicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025
2025-02-27 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at Upcoming Investor Conferences in March 2025
2025-02-19 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Full-Year 2024 Financial Results and Corporate Updates
2025-02-10 07:00U:FOLDNews ReleaseAmicus Therapeutics to Announce Full-Year 2024 Financial Results on February 19, 2025
2025-02-03 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Presentations and Posters at the 21st Annual WORLDSymposium(TM) 2025
2025-01-12 16:00U:FOLDNews ReleaseAmicus Therapeutics Reports Preliminary 2024 Revenue and Provides 2025 Strategic Outlook
2025-01-02 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
2024-11-06 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Third Quarter 2024 Financial Results and Corporate Updates
2024-11-01 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at Upcoming Investor Conferences in November 2024
2024-10-28 07:00U:FOLDNews ReleaseAmicus Therapeutics to Announce Third Quarter 2024 Financial Results on November 6, 2024